Literature DB >> 18249232

Metastatic lymph node number in epithelial ovarian carcinoma: does it have any clinical significance?

Ali Ayhan1, Murat Gultekin, Polat Dursun, Nasuh Utku Dogan, Guldeniz Aksan, Suleyman Guven, Melih Velipasaoglu, Kunter Yuce.   

Abstract

OBJECTIVE: To analyze the clinicopathological correlations of metastatic lymph node (LN) numbers in patients with epithelial ovarian carcinoma.
METHOD: A total of 328 patients with epithelial ovarian carcinoma diagnosed and treated at Hacettepe University Hospital during 1982-2005 were retrospectively reviewed. Patients' age, number of resected lymph nodes, clinical disease stage, preoperative Ca-125 levels, peritoneal cytology, presence of ascites, tumor histology, tumor grade, maximal tumor diameter, cytoreductive success, overall and disease-free survivals were compared with respect to the number of metastatic lymph nodes (< 4 vs. > or = 4).
RESULTS: The mean number of resected lymph nodes was 24.5 and mean number of metastatic lymph nodes was 6.2. About 47.3% (n=155) of the patients had < 4 metastatic lymph nodes and the remaining 52.7% of patients (n=173) had > or = 4 metastatic lymph nodes. Univariate comparison of the two groups relived preoperative Ca-125 values, peritoneal cytology and clinical disease stage to be significantly different among the two groups. However, multivariate analysis revealed a high Ca-125 level (> or = 500 IU/l) to be unique factor significantly different among the groups. Survival analysis also could not find a significant difference with respect to overall and disease-free survival among the groups.
CONCLUSION: The number of metastatic lymph nodes increases as the preoperative Ca-125 values increase. Other patient characteristics do not have a significant effect on the number of metastatic lymph nodes. Metastatic LN number does not have a prognostic significance in terms of either the overall or the disease-free survival. Prospective series are needed for a definitive conclusion.

Entities:  

Mesh:

Year:  2008        PMID: 18249232     DOI: 10.1016/j.ygyno.2007.09.014

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

Review 1.  Low-grade epithelial ovarian cancer: what a radiologist should know.

Authors:  Sherif Elsherif; Sanaz Javadi; Chitra Viswanathan; Silvana Faria; Priya Bhosale
Journal:  Br J Radiol       Date:  2019-01-31       Impact factor: 3.039

2.  Evaluation of intraoperative and postoperative complications related to lymphadenectomy in ovarian cancer patients.

Authors:  Leszek Jaroslaw Gmyrek; Joanna Jonska-Gmyrek; Piotr Sobiczewski; Grzegorz Panek; Mariusz Bidzinski
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

3.  Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.

Authors:  Sai Kiran Sharma; Kuntal K Sevak; Sebastien Monette; Sean D Carlin; James C Knight; Frank R Wuest; Evis Sala; Brian M Zeglis; Jason S Lewis
Journal:  J Nucl Med       Date:  2016-02-02       Impact factor: 10.057

4.  Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification.

Authors:  E Sun Paik; Yoo-Young Lee; Eun-Jung Lee; Chel Hun Choi; Tae-Joong Kim; Jeong-Won Lee; Duk-Soo Bae; Byoung-Gie Kim
Journal:  Obstet Gynecol Sci       Date:  2015-03-16

5.  Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?

Authors:  Hanifi Sahin; Mehmet Mutlu Meydanli; Mustafa Erkan Sari; Ibrahim Yalcin; Gonca Çoban; Nazlı Topfedaisi Ozkan; Zeliha Firat Cuylan; Baki Erdem; Kemal Gungorduk; Özgür Akbayir; Murat Dede; Mustafa Coşkun Salman; Tayfun Güngör; Ali Ayhan
Journal:  J Ovarian Res       Date:  2018-03-05       Impact factor: 4.234

6.  The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer.

Authors:  Ting Deng; Qidan Huang; Ting Wan; Xiaoling Luo; Yanling Feng; He Huang; Jihong Liu
Journal:  J Gynecol Oncol       Date:  2021-05       Impact factor: 4.401

7.  Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures.

Authors:  Junsong Chen; Jing Wang; Dengyu Chen; Jie Yang; Cuiping Yang; Yunxia Zhang; Hongyi Zhang; Jun Dou
Journal:  BMC Cell Biol       Date:  2013-01-31       Impact factor: 4.241

8.  IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer.

Authors:  Yunxia Zhang; Jing Wang; Di Wu; Miao Li; Fenshu Zhao; Mulan Ren; Yunlong Cai; Jun Dou
Journal:  Onco Targets Ther       Date:  2018-04-10       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.